(Q33888231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Matrix metalloproteinase inhibitors: applications in oncology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Ahmad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C S Karapetis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C A Hawkins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P G Harper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

387-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10759405%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006386406584

5 November 2019

exact match

0 references

cites work

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

1 reference

12 December 2020

Inhibition of angiogenesis by tissue inhibitor of metalloproteinase

1 reference

12 December 2020

Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review)

1 reference

12 December 2020

Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.

1 reference

12 December 2020

Marimastat (BB2516): current status of development

1 reference

12 December 2020

Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma

1 reference

12 December 2020

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

1 reference

12 December 2020

Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression

1 reference

12 December 2020

Matrix metalloproteinases and their inhibitors.

1 reference

12 December 2020

Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation

1 reference

12 December 2020

Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells

1 reference

12 December 2020

Matrix-degrading proteases and angiogenesis during development and tumor formation.

1 reference

12 December 2020

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model

1 reference

12 December 2020

A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts

1 reference

12 December 2020

Metalloproteinases and cancer invasion and metastasis

1 reference

12 December 2020

Matrix metalloproteinase inhibitors in arthritis

1 reference

12 December 2020

A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer

1 reference

12 December 2020

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

12 December 2020

Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta

1 reference

12 December 2020

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

12 December 2020

Role of matrix metalloproteinases and their inhibitors in pancreatic cancer

1 reference

12 December 2020

Low molecular weight inhibitors in corneal ulceration

1 reference

12 December 2020

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

12 December 2020

Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis

1 reference

12 December 2020

Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer

1 reference

12 December 2020

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

1 reference

12 December 2020

Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia

1 reference

12 December 2020

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

12 December 2020

Mechanisms of tumour metastasis

1 reference

12 December 2020

Clinical studies with matrix metalloproteinase inhibitors

1 reference

12 December 2020

Correlation between stromelysin-3 mRNA level and outcome of human breast cancer

1 reference

12 December 2020

Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis

1 reference

12 December 2020

Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.

1 reference

12 December 2020

Role of integrins in angiogenesis

1 reference

12 December 2020

Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis

1 reference

12 December 2020

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

12 December 2020

Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy

1 reference

12 December 2020

Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor

1 reference

12 December 2020

Matrix metalloproteinase inhibition: a review of anti-tumour activity

1 reference

12 December 2020

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

1 reference

12 December 2020

The experimental study of tumor progression: a review.

1 reference

12 December 2020

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

1 reference

12 December 2020

Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors

1 reference

12 December 2020

Relation of neovascularisation to metastasis of non-small-cell lung cancer

1 reference

12 December 2020

Tumour marker levels during marimastat therapy

1 reference

12 December 2020

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

12 December 2020

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

1 reference

12 December 2020

Matrix metalloproteinases in gastrointestinal cancer

1 reference

12 December 2020

Matrix metalloproteinase inhibitors

1 reference

12 December 2020

SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines

1 reference

12 December 2020

Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases

1 reference

12 December 2020

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020